

6.	Restructuring and Related Charges

In July 2016, the Company's Board of Directors approved a $100.0 million to $125.0 million restructuring program ("the 2016 Mallinckrodt Program") designed to further improve the Company's cost structure as it continues to transform the business. The 2016 Mallinckrodt Program is expected to include actions across both the Specialty Brands segment and the Specialty Generics Disposal Group, as well as within corporate functions. There is no specified time period associated with the 2016 Mallinckrodt Program. In addition to the 2016 Mallinckrodt Program, the Company takes certain restructuring actions to generate synergies from its acquisitions.

In February 2018, the Company's Board of Directors approved a $100.0 million to $125.0 million restructuring program ("the 2018 Mallinckrodt Program") that is of similar design as the 2016 Mallinckrodt Program. The utilization of the 2018 Mallinckrodt Program will commence upon completion of the 2016 Mallinckrodt Program. There is no specified time period associated with the 2018 Mallinckrodt Program.

Net restructuring and related charges by segment are as follows:



	Three Months Ended
	March 30, 2018		March 31, 2017
Specialty Brands	$	17.1	$	9.2
Corporate	6.0		2.1
Restructuring and related charges, net	23.1		11.3
Less: accelerated depreciation	—		(1.0		)
Restructuring charges, net	$	23.1	$	10.3

Net restructuring and related charges by program are comprised of the following:



	Three Months Ended
	March 30, 2018		March 31, 2017
2016 Mallinckrodt Program	$	3.1	$	11.3
Acquisitions	20.0		—
Total	23.1		11.3
Less: accelerated depreciation	—		(1.0		)
Total charges expected to be settled in cash	$	23.1	$	10.3

The following table summarizes cash activity for restructuring reserves, substantially all of which are related to employee severance and benefits:



	2016 Mallinckrodt Program			Acquisitions			Total
Balance at December 29, 2017	$	14.1		$	0.8		$	14.9
Charges	3.3			20.0			23.3
Changes in estimate	(0.2		)	—			(0.2		)
Cash payments	(3.3		)	(11.5		)	(14.8		)
Balance at March 30, 2018	$	13.9		$	9.3		$	23.2

Net restructuring and related charges, including associated asset impairments, incurred cumulative-to-date related to the 2016 Mallinckrodt Program was as follows:



	2016 Mallinckrodt Program
Specialty Brands	$	33.1
Corporate	11.7
Specialty Generics Disposal Group	14.2
	$	59.0

Substantially all of the restructuring reserves were included in accrued and other current liabilities on the Company's unaudited condensed consolidated balance sheets.